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What’s new? 
 For the first time a case of Type 1 diabetes and Hereditary Neuropathy with liability to 
Pressure Palsies (HNPP) is described. 
 Longstanding motor and sensory symptoms were previously attributed to golfer’s elbow, 
diabetic neuropathy and spinal degenerative disease. 
 Many cases of HNPP are thought to remain undiagnosed. 
 This case suggests that the differential diagnosis of peripheral neuropathy in people with 
diabetes and other co-morbidities may be challenging and requires a careful and 
comprehensive approach.  
 
Abstract  
Background Hereditary Neuropathy with liability to Pressure Palsies (HNPP) is an autosomal 
dominant neuropathy, associated with deletion of the Peripheral Myelin Protein-22 (PMP-22) gene, 
causing recurrent painless palsies with age of onset between 10 and 30 years old. Only a few cases of 
Type 2 Diabetes and HNPP have been described and the coexistence of HNPP and Type 1 diabetes 
has never been reported.  
Case report A 54-year old man with a history of Type 1 diabetes, managed with continuous 
subcutaneous insulin infusion (CSII), presented with deterioration of long-standing motor and sensory 
symptoms, previously attributed to golfer’s elbow, diabetic neuropathy and spinal degenerative 
disease. He had multilevel severe spine degenerative changes and L4/L5 and L5/S1 root 
impingements with a L4/L5 discectomy performed when he was 25 years old. On physical 
examination he had normal power and distal hypoaesthesia of the digits and plantar aspect of the feet. 
Investigations revealed normal full blood count, liver and renal function, electrolytes, vitamin B12 
and serum folate. He suffered from primary hypothyroidism and thyroid function tests indicated 
adequate levothyroxine replacement. Nerve conduction studies revealed a generalized demyelinating 
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sensorimotor neuropathy, with more severe involvement of nerves over entrapment sites. Further 
history that his father suffered from episodes of weakness and numbness was elicited. Genetic 
analysis revealed one copy of the PMP22 gene at 17p11.2 confirming the diagnosis of HNPP.  
Conclusion In people with diabetes the evaluation of peripheral neuropathy should include a careful 
history, a comprehensive physical examination, blood tests and in some cases nerve conduction 
studies and genetic testing. 
 
<H1>Background  
Hereditary Neuropathy with liability to Pressure Palsies (HNPP) is an autosomal dominant 
neuropathy associated with deletion of the Peripheral Myelin Protein-22 (PMP-22) gene causing 
recurrent painless palsies with age of onset between 10 and 30 years old (1,2). PMP-22 is a gene 
encoding the peripheral myelin protein which plays a crucial role in the formation of myelin. The 
prevalence of HNPP is estimated between 7.3 to 16 cases per 100,000, although many cases are 
thought to remain undiagnosed (3,4). While the coexistence of HNPP and Type 2 diabetes has 
previously been described (5), this is the first report of a person with Type 1 diabetes, HNPP and 
diabetic peripheral neuropathy.  
 
<H1>Case report 
A 54-year old man with a 14-year history of Type 1 diabetes, managed with continuous subcutaneous 
insulin infusion (CSII), was seen at the authors’ clinic. He presented with deterioration of 
longstanding motor and sensory symptoms which had previously been attributed to golfer’s elbow 
and spinal degenerative disease. He reported recent worsening of an intermittent right leg numbness 
after prolonged sitting and episodes of parasthesia of his right arm after nocturnal sleep. He was 
known to have multilevel vertebral degenerative changes with L4/L5 and L5/S1 root impingements. 
At the age of 25 years old he had a L4/L5 discectomy for low back pain and right leg numbness 
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associated with weakness. Previous lumbar MRI scans had shown degenerative changes with 
foraminal impingement at various levels, with no significant progression over time. Nerve conduction 
studies performed in other hospitals had documented findings suggestive of a superimposed diabetic 
peripheral neuropathy. His medical history also included primary hypothyroidism, adequately 
replaced with levothyroxine. On examination, he had bilateral pes cavus, hammer toes and mild 
muscle wasting in the lower limbs. Power was normal in all four limbs. Deep tendon reflexes were 
reduced but symmetrical. There was hypoaesthesia of the toes and soles. The plantar responses were 
downgoing. A panel of blood tests including full blood count, renal and liver function, ESR, vitamin 
B12, methylmalonic acid and serum protein electrophoresis was unremarkable. His HbA1c was 71 
mmol/mol (8.6%). Repeat nerve conduction studies revealed a generalized demyelinating 
sensorimotor neuropathy with more severe involvement of nerves over entrapment sites (median 
neuropathy at the wrist, ulnar at the elbow and peroneal at the knee) (Table 1). The findings, although 
compatible with a diabetic neuropathy, showed rather slower velocities than were typical. Further 
questioning revealed history of recurrent right foot drop at the age of 18–20 years old, particularly 
after sitting with the right leg crossed over the left. The weakness recovered over several weeks. He 
had also experienced recurrent painless weakness of right shoulder abduction or elbow flexion 
following gym sessions with a weight over his shoulders. He recalled that his father had had similar 
symptoms of recurrent numbness and weakness. His history raised the suspicion of a demyelinating 
hereditary neuropathy. A subsequent multiplex ligation-dependent probe amplification analysis 
revealed one copy of the PMP22 gene at 17p11.2, confirming the diagnosis of HNPP. 
 
<H1>Discussion  
HNPP leads to episodic, painless, focal motor and sensory peripheral neuropathy and causes attacks 
of numbness and weakness (6). It is known that the most vulnerable nerves are the peroneal and the 
ulnar nerves (30–48% and 21–28%, respectively), followed by the brachial plexus, radial nerve and 
median nerve (2,7). In this case, the neurological symptoms had been attributed to a spinal 
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degenerative process, recurrent tendinitis of the right elbow, and a superimposed diabetic neuropathy. 
HNPP and diabetic neuropathy may have similar neurophysiological features and, although sensory 
nerve conduction velocity slowing and distal motor latency prolongation is said to be more marked in 
HNPP (8), the distinction is not absolute. The main clue to the correct diagnosis came from the 
history of typical recurrent pressure palsies and his detailed family history. Some unusual associations 
of HNPP with other pathologies such as hypothyroidism have been described and are believed to 
aggravate HNPP neurological symptoms (9). As the concurrence of HNPP and diabetes is rare, it is 
not known if diabetes exacerbates the nerve injury in this genetic condition. This case confirms that 
the differential diagnosis of peripheral neuropathy in a person with diabetes can be challenging and 
warrants specialist consultation in the presence of atypical features (Table 2) (10-12). Nerve 
conduction studies represent an easy and accurate method for determining which patients may have 
HNPP but genetic testing is the most reliable tool for the diagnosis. In the present case, the correct 
diagnosis allowed the adoption of strategies (activity modification and protective padding) to prevent 
further progression in nerve injury and facilitated appropriate genetic counselling and management 
(4). Furthermore, beyond the uncommon concomitancy of Type 1 diabetes, HNPP and peripheral 
diabetic neuropathy and the misleading presence of spine disease, this report provides the reader with 
an important key clinical message. In people with diabetes and nerve damage the diagnostic process is 
not always straightforward and should include meticulous history taking, a comprehensive physical 
examination and consideration of nerve conduction studies. 
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Table 1  Neurophysiology results ǂ 
 
Sensory studies Amplitude (uV) Norm (uV) CV (m/s) Norm (m/s) 
     
Median     
Digit II (index finger) absent > 8    
Digit III (long finger) absent > 8    
Mid palm absent    
Ulnar     
Digit V (little finger) 3  > 6 35  > 50 
Mid palm 6   39  > 50 
Radial     
Forearm 4  > 13 34  > 50 
Superficial peroneal     
Lower leg absent     
Sural     
Lower leg absent     
 
Motor studies DML 
(ms) 
CMAP 
(mV) 
Segment MCV* 
(m/s) 
Median     
Wrist 9.9 
 TLI 0.22 
2.3  Abductor pollicis brevis-Wrist  
Elbow 16.6  1.4  Wrist-Elbow 38  
 
Ulnar     
Wrist 4.4  10.2  Abductor DM-Wrist   
Below elbow 9.3  7.8  Wrist-Below elbow 49  
Above elbow 13.5  5.5  Below elbow-Above elbow 29  
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Peroneal     
Ankle 6.5  0.1  Extensor Digitorum Brevis-Ankle   
Fibula (head) 22.4  0.1  Ankle-Fibula (head) 25  
 
Peroneal     
Fibula (head) 4.9  2.0  Tibialis anterior-Fibula (head)   
Popliteal fossa 7.8  2.3  Fibula (head)-Popliteal fossa 29  
 
Tibial     
Ankle 5.3  1.2  Abductor Hallucis-Ankle   
 
Median-Ulnar comparison 
Median    DML difference: 
Wrist 6.4 1.6 Wrist-2nd Lumbrical  
Ulnar    3.6 ms 
Wrist 2.8 2.9 Wrist-2nd Interosseous  
 
F-Wave Studies 
Nerve Minimum F-Latency  
Median 40.8  
Ulnar 35.7  
   
ǂAll results shown were from the right side. 
*Normal values for upper limbs > 50 m/s, lower limbs > 40 m/s. 
CV, conduction velocity; Norm, normative data; DML, distal motor latency; CMAP, compound muscle action 
potential; MCV, maximum conduction velocity to onset of CMAP; TLI, terminal latency index (normal > 0.34). 
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Table 2 Features suggesting further investigation of peripheral 
neuropathy in diabetes 
 
 Acute or subacute onset of symptoms  
 Rapidly progressive symptoms 
 Family history of sensory and motor symptoms 
 Asymmetry of signs or symptoms  
 Motor greater than sensory neuropathy 
 Multifocal symptoms  
 Sensory neuropathies causing gait ataxia and 
proprioceptive dysfunction 
 Symptoms associated with severe dysautonomia  
 Severe symptoms, functionally limiting  
